Edward van der Horst
Chief Tech/Sci/R&D Officer at SENSEI BIOTHERAPEUTICS, INC.
Net worth: 35 445 $ as of 2024-04-29
Edward van der Horst active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-06 | - |
| Corporate Officer/Principal | 2019-08-31 | 2022-12-06 |
Career history of Edward van der Horst
Former positions of Edward van der Horst
| Companies | Position | Start | End |
|---|---|---|---|
Zenith Epigenetics Ltd.
 Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Corporate Officer/Principal | 2017-06-30 | 2019-07-31 |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Corporate Officer/Principal | 2010-09-30 | 2016-12-31 |
Training of Edward van der Horst
| Ludwig-Maximilians-Universität München | Graduate Degree |
| Max Planck Institute of Biochemistry | Doctorate Degree |
Statistics
International
| United States | 3 |
| Germany | 3 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Zenith Epigenetics Ltd.
Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Commercial Services |
- Stock Market
- Insiders
- Edward van der Horst
- Experience
